Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-28

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Granules Pharmaceuticals Inc. to approve a bupropion hydrochloride granule formulation under the ANDA. This act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)